Literature DB >> 4719675

Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog.

M Kaden, P Harding, J B Field.   

Abstract

Extraction of insulin by the liver after administration of glucose in the duodenum has been studied in fourteen anesthetized dogs. Plasma insulin and glucose were measured in the portal vein hepatic vein and hepatic artery. During the control period 40+/-3% of the approximately 11 mU of insulin presented to the liver/min was removed during a single transhepatic passage. Within 5 min after glucose administration, the amount of insulin reaching the liver increased significantly. In some animals this increase preceded any significant increase in the glucose concentration of the femoral artery. After glucose administration, hepatic extraction of insulin remained unchanged in five animals and rose significantly in nine. In five of the latter animals, the increase may have been more apparent than real due to nonrepresentative sampling of hepatic venous blood. However, for the whole group of animals, comparison of arterial insulin levels with the amount of insulin delivered to the liver suggested a transient increase in insulin extraction between 5 and 50 min after glucose administration. In no animal was there a decrease in the proportion of insulin extracted by the liver after glucose administration. The results indicate that the extraction process is not saturable at physiological insulin levels. Prior to glucose administration, net hepatic glucose output averaged between 30 and 40 mg/min. After glucose administration, the liver began to take up glucose and there was a significant correlation between hepatic glucose uptake and the amount of insulin reaching the liver. However, since the amount of glucose presented to the liver also increased, it is not established that the insulin was responsible for the change in hepatic carbohydrate metabolism. The data demonstrate an increase in the absolute amount of insulin extracted by the liver after glucose administration and an important role for the liver in regulating peripheral insulin concentrations.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4719675      PMCID: PMC302484          DOI: 10.1172/JCI107386

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

Review 1.  THE METABOLISM OF INSULIN.

Authors:  I A MIRSKY
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

Review 2.  Role of insulin in the hepatic handling of glucose.

Authors:  L L Madison
Journal:  Arch Intern Med       Date:  1969-03

3.  Dynamics of insulin secretion by the perfused rat pancreas.

Authors:  D L Curry; L L Bennett; G M Grodsky
Journal:  Endocrinology       Date:  1968-09       Impact factor: 4.736

Review 4.  Measurement of insulin secretion. A review of current methods.

Authors:  P H Wright
Journal:  Diabetes       Date:  1968-10       Impact factor: 9.461

5.  Quantitative determination of insulin output following an intravenous glucose tolerance test in the dog.

Authors:  A M Rappaport; J K Davidson; T Kawamura; B J Lin; S Zelin; J Henderson; R E Haist
Journal:  Can J Physiol Pharmacol       Date:  1968-05       Impact factor: 2.273

6.  Matched rates of insulin infusion and secretion and concurrent tracer-determined rates of glucose appearance and disappearance in fasting dogs.

Authors:  M Vranic; G A Wrenshall
Journal:  Can J Physiol Pharmacol       Date:  1968-05       Impact factor: 2.273

7.  Plasma insulin responses to glucose in femoral, hepatic, and pancreatic veins in dogs.

Authors:  Y Kanazawa; T Kuzuya; T Ide; K Kosaka
Journal:  Am J Physiol       Date:  1966-08

8.  Insulin output via the pancreatic vein and plasma insulin response to glucose in dogs.

Authors:  Y Kanazawa; T Kuzuya; T Ide
Journal:  Am J Physiol       Date:  1968-09

9.  Effect of D-glucose or D-ribose on the turnover of glucose in pancreatectomized dogs maintained on a matched intraportal infusion of insulin.

Authors:  K Ishiwata; G Hetenyi; M Vranic
Journal:  Diabetes       Date:  1969-12       Impact factor: 9.461

10.  Insulin delivery rate into plasma in normal and diabetic subjects.

Authors:  M P Stern; J W Farquhar; A Silvers; G M Reaven
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

View more
  34 in total

1.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.

Authors:  S R Myers; D W Biggers; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  A study on the hyperinsulinism of late pregnancy.

Authors:  I Piva; G Erle; M Thiella; L Lora; M Strazzabosco; N Sicolo; G Federspil
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

3.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  The role of the liver in glucagon metabolism.

Authors:  J B Jaspan; A H Huen; C G Morley; A R Moossa; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  Insulin degradation in hepatic cirrhosis.

Authors:  J Ono; D G Hutson; R S Dombro; R Zeppa; T Katsuki
Journal:  Gastroenterol Jpn       Date:  1984-04

7.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

8.  Kinetics of human connecting peptide in normal and diabetic subjects.

Authors:  O K Faber; C Hagen; C Binder; J Markussen; V K Naithani; P M Blix; H Kuzuya; D L Horwitz; A H Rubenstein; N Rossing
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  The measurement and validation of the nonsteady-state rates of C-peptide appearance in the dog.

Authors:  T Morishima; S Pye; K Polonsky; J Radziuk
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

Review 10.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.